Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
Background: Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation efficacy. However, the mechanism for this beneficial effect is still unclear. Since cardiac mitochondria have been shown to pl...
Saved in:
Main Authors: | Siriporn C. Chattipakorn, Savitree Thummasorn, Jantira Sanit, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904509817&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/45397 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
by: Siriporn C. Chattipakorn, et al.
Published: (2018) -
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
by: Chattipakorn S.C., et al.
Published: (2014) -
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
by: Chattipakorn S.C., et al.
Published: (2014) -
Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria
by: Savitree Thummasorn, et al.
Published: (2018) -
Effects of cilostazol in the heart
by: Natnicha Kanlop, et al.
Published: (2018)